Jing Cui

439 total citations
19 papers, 328 citations indexed

About

Jing Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jing Cui has authored 19 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Jing Cui's work include Cancer-related molecular mechanisms research (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Jing Cui is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Jing Cui collaborates with scholars based in China, United States and Romania. Jing Cui's co-authors include Jiongxin Xiong, Yao Guo, Heshui Wu, Tao Peng, Xiaoxiao Zhou, Kun Liu, Xinlai Qian, Shuling Song, Yingying Lin and Rogelio Medina and has published in prestigious journals such as Oncogene, BioMed Research International and Cells.

In The Last Decade

Jing Cui

19 papers receiving 326 citations

Peers

Countries citing papers authored by Jing Cui

Since Specialization

Citations

This map shows the geographic impact of Jing Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Cui more than expected).

Fields of papers citing papers by Jing Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Cui. The network helps show where Jing Cui may publish in the future.

Co-authorship network of co-authors of Jing Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Cui. A scholar is included among the top collaborators of Jing Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Cui. Jing Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	sEV-mediated intercellular transformation from MGAT4AHigh to MGAT4ALow tumor cells via the HOTAIRM1/miR-196b-5p axis promotes apoptosis resistance in CTCL 2025 ·Oncogene ·Jiachen Sun, Tingting Li, Jing Cui, (unknown), Guanyu Wang, (unknown), Chunlei Zhang, Yimeng Wang	1
2	Neuropeptide-mediated activation of astrocytes improves stress resilience in mice by modulating cortical neural synapses 2024 ·Acta Pharmacologica Sinica ·Jing Cui, Xiaoran Wang, Jie Yu, Borui Zhang, Yafei Shi, Kwok‐Fai So, Li Zhang, Ji‐an Wei	1
3	Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression 2022 ·Cells ·(unknown), Taoyu Chen, Xueyi Liang, Shanmiao Gou, Jiongxin Xiong, Jing Cui, Tao Peng	19
4	High DND1 Level Indicates a Poor Prognostic Factor in Prostate Cancer 2021 ·Disease Markers ·(unknown), Xiaotong Yang, (unknown), Fan Wang, Jing Cui, Bin Li, (unknown), (unknown), (unknown)	2
5	Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling 2021 ·Molecular Medicine ·Jing Cui, Yao Guo, Heshui Wu, Jiongxin Xiong, (unknown)	33
6	Cytokine-induced killer cells carrying recombinant oncolytic adenovirus expressing p21Ras scFv inhibited liver cancer 2021 ·Journal of Cancer ·Fang Dai, Pengbo Zhang, Qiang Feng, Xinyan Pan, Shuling Song, Jing Cui, Ju-Lun Yang	13
7	Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer 2021 ·Journal of Experimental & Clinical Cancer Research ·Xiaoxiao Zhou, Kun Liu, Jing Cui, Jiongxin Xiong, Heshui Wu, Tao Peng, Yao Guo	57
8	MicroRNA‐384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB 2020 ·BioMed Research International ·Yong‐Xia Wang, Beixi Wang, Hong Zhou, Xiangnan Zhang, Xinlai Qian, Jing Cui	13
9	The Immunoreactivity of the Anti-p21Ras Single-Chain Fragment Variant KGH-R1 and its Predicted Binding Sites to p21Ras 2020 ·Immunotherapy ·(unknown), Xinyan Pan, Qiang Feng, Hong Zou, Jing Cui, Yanping He, Ying Luo, Ju-Lun Yang	4
10	Blocking lncRNA H19-miR-19a-Id2 axis attenuates hypoxia/ischemia induced neuronal injury 2019 ·Aging ·(unknown), Yongming Qiu, Yingying Lin, Rogelio Medina, (unknown), Jared S. Rosenblum, Jing Cui, Zezhi Li, Xiaohua Zhang, Liemei Guo	53
11	Prognostic and clinicopathological roles of long non-coding RNA XIST in human cancers: a meta-analysis 2018 ·Translational Cancer Research ·Liang Shen, Changzhong Li, Ming Liu, (unknown), Qin Chang, Jing Cui	1
12	Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression 2018 ·Molecular Therapy — Oncolytics ·Mingjuan Wang, (unknown), Qiang Feng, Xinyan Pan, Shuling Song, Jing Cui, Jin Lei, Hong Fang, Ju-Lun Yang	9
13	Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells 2018 ·BMC Cancer ·(unknown), Shuang Bai, Qiang Feng, Xinyan Pan, Shuling Song, Hong Fang, Jing Cui, Ju-Lun Yang	17
14	Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer 2017 ·Cellular Physiology and Biochemistry ·Guoyang He, Liyuan Zou, (unknown), (unknown), Xinlai Qian, Jing Cui	16
15	Optimization of 1H-indazol-3-amine derivatives as potent fibroblast growth factor receptor inhibitors 2017 ·Bioorganic & Medicinal Chemistry Letters ·Jing Cui, Peng Xia, Dingding Gao, Yang Dai, Jing Ai, Yingxia Li	15
16	Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use 2017 ·Molecular Medicine Reports ·Huijie Jia, Jing Cui, Xiaolong Jia, Jingjing Zhao, Yuchen Feng, (unknown), Dan Zang, Jian Yu, Tiesuo Zhao, Hui Wang, Kailin Xu	18
17	HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression 2017 ·BioMed Research International ·Yong‐Xia Wang, (unknown), (unknown), (unknown), Jing Cui, Xinlai Qian	12
18	Synthesis and biological evaluation of geldanamycin analogs against human cancer cells 2015 ·Cancer Chemotherapy and Pharmacology ·Yanping Li, (unknown), Jiajia Shen, Jing Cui, (unknown), Zhen Wang, Zhuorong Li	12
19	Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma 2013 ·Diseases of the Esophagus ·(unknown), (unknown), (unknown), Feng Du, Bette Liu, (unknown), (unknown), (unknown), Xiaofang Zhao, (unknown), Jing Cui, Fuyou Zhou, (unknown), (unknown), Yan Zhou, Lin Zhu, (unknown), (unknown)	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact